← FDA DRUG APPROVALS

FDA ANDA · ANDA091295

CYPROHEPTADINE HYDROCHLORIDE

Sponsor: PHARM ASSOC

APPLICATION
ANDA091295
TYPE
ANDA
ORIGINAL APPROVAL
2013-03-28
LATEST ACTION
2013-03-28
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

CYPROHEPTADINE HYDROCHLORIDEDiscontinued
CYPROHEPTADINE HYDROCHLORIDE 2MG/5ML · SYRUP · ORAL

Approval history

2013-03-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →